News
Personalized skin cancer vaccine demonstrates long-term effectiveness
January 25, 2021 /
New research published in the journal Nature is outlining the long-term efficacy of a novel type of cancer vaccine. The research followed eight skin cancer patients and discovered the experimental treatment offers durable and persistent immune responses to cancer cells up to four years later.
MATR Supporters (view all)
Posted in: Incubators and R&D, Cool Stuff That's Coming
Sorry, we couldn't find any posts. Please try a different search.